Pure Global

Multiparametric Bronchopulmonary Prediction - Trial NCT04785859

Access comprehensive clinical trial information for NCT04785859 through Pure Global AI's free database. This phase not specified trial is sponsored by Andaluz Health Service and is currently Recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 240 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04785859
Recruiting
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT04785859
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Multiparametric Bronchopulmonary Prediction
Multiparametric Prediction of the Risk of Moderate-severe Bronchopulmonary Dysplasia in Neonates Born Before 30 Weeks of Gestation

Study Focus

BPD prediction

Observational

diagnostic test

Sponsor & Location

Andaluz Health Service

Cadiz, Spain

Timeline & Enrollment

N/A

Dec 01, 2020

Mar 01, 2024

240 participants

Primary Outcome

multiparametric moderate-severe BPD prediction

Summary

INTRODUCTION: Current Neonatology has failed to reduce the incidence of moderate-severe
 bronchopulmonary dysplasia (BPD). Although multiple models for predicting the risk of
 dysplasia in preterm infants have been studied, none have been implemented in clinical
 practice.
 
 OBJECTIVE: To calculate a mathematical model to predict moderate-severe bronchopulmonary
 dysplasia in newborns before 30 weeks of gestation based on pre and postnatal clinical
 variables, lung ultrasound images and detection of biomarkers in nasopharyngeal aspirate.
 
 METHODOLOGY: Multicenter case-control study, in which 10 Spanish neonatal intensive care
 units (NICU) will participate. All participants will undergo a lung ultrasound in the first
 24 hours, on the third day of life, at one week and two weeks of life, a nasopharyngeal
 aspirate at one week of life, and cardiac ultrasound at one week and two weeks of life. It is
 expected to include 240 patients in 29 months of study among all participating units: 200 for
 the calculation of the model, and 40 more for its subsequent validation. These will be
 divided between those with a diagnosis of moderate-severe BPD and those without, and the
 values of each of the variables described in the methodology section will be compared between
 the two groups. Those with a significant difference will be entered into a logistic
 regression model to calculate those that best predict the final diagnosis. With the results
 of the calculated model, a mobile application will be created with a risk of moderate-severe
 BPD calculator in this population, for its worldwide distribution.

ICD-10 Classifications

Bronchopulmonary dysplasia originating in the perinatal period
Congenital bronchomalacia
Bronchopneumonia, unspecified
Other congenital malformations of bronchus
Diseases of bronchus, not elsewhere classified

Data Source

ClinicalTrials.gov

NCT04785859

Non-Device Trial